Medtronic 2012 Annual Report Download - page 43

Item 1B. Unresolved Staff Comments
None.
Item 2. Properties
Our principal offices are owned by us and located in the Minneapolis, Minnesota metropolitan area.
Manufacturing or research facilities are located in Arizona, California, Colorado, Connecticut, Florida,
Indiana, Massachusetts, Michigan, Minnesota, New Jersey, Texas, Puerto Rico, Canada, France, Germany,
Ireland, Israel, Italy, Mexico, The Netherlands, Singapore, and Switzerland. Our total manufacturing and
research space is approximately 3.8 million square feet, of which approximately 40 percent is owned by us
and the balance is leased.
We also maintain sales and administrative offices in the U.S. at approximately 43 locations in 28 states
or jurisdictions and outside the U.S. at approximately 111 locations in over 44 countries. Most of these
locations are leased. We are using substantially all of our currently available productive space to develop,
manufacture, and market our products. Our facilities are in good operating condition, suitable for their
respective uses and adequate for current needs.
Item 3. Legal Proceedings
A discussion of the Company’s policies with respect to legal proceedings is discussed in our
contingencies footnote as described in Note 17 to the consolidated financial statements in “Item 8. Financial
Statements and Supplementary Data” in this Annual Report on Form 10-K.
Item 4. Mine Safety Disclosures
Not applicable.
PART II
Item 5. Market for Medtronic’s Common Equity, Related Shareholder Matters, and Issuer Purchases of
Equity Securities
The Company’s common stock is listed on the New York Stock Exchange under the symbol “MDT.”
In June 2009 and June 2011, the Company’s Board of Directors authorized the repurchase of 60 million
and 75 million shares of the Company’s common stock, respectively. As of April 27, 2012, the Company had
used the entire amount authorized under the June 2009 repurchase program and 16.6 million of the
75.0 million shares authorized under the June 2011 program. As authorized by the Board of Directors our
program expires when its total number of authorized shares has been repurchased.
The following table provides information about shares repurchased by the Company during the fourth
quarter of fiscal year 2012:
Total Number of Shares Maximum Number
Average Price Purchased as a Part of of Shares that May
Total Number of Paid per Publicly Announced Yet Be Purchased
Fiscal Period Shares Purchased Share Program Under the Program
____________ ________________ _____________ ______________________ __________________
01/28/12-02/24/12 . . . . . . . . . . 11,275,133 $39.91 11,275,133 63,897,726
02/25/12-03/30/12 . . . . . . . . . . 5,459,269 38.47 5,459,269 58,438,457
03/31/12-04/27/12 . . . . . . . . . . –– –58,438,457
_____________ _____________
Total . . . . . . . . . . . . . . . . . . . . . 16,734,402 $39.44 16,734,402 58,438,457
_____________ _____________
_____________ _____________
On June 25, 2012, there were approximately 48,900 shareholders of record of the Company’s common
stock. Cash dividends declared and paid totaled 24.25 cents per share for each quarter of fiscal year 2012
and 22.50 cents per share for each quarter of fiscal year 2011. The following prices are the high and low
market sales quotations per share of the Company’s common stock, for the periods indicated:
Fiscal Qtr. 1st Qtr. 2nd Qtr. 3rd Qtr. 4th Qtr.
__________ ________ ________ ________ ________
2012 High . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $43.33 $36.36 $40.16 $40.78
2012 Low . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35.55 30.18 33.11 36.88
2011 High . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44.31 38.08 39.53 42.20
2011 Low . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35.13 30.80 33.33 36.31
26